Purpose: To assess and compare early modifications in inner retinal layer thickness and optical coherence tomography angiography parameters in patients with diabetes mellitus (DM) Types 1 and 2 without clinical signs of diabetic retinopathy.
D
iabetic retinopathy (DR) is the most important ocular complication in diabetes mellitus (DM). 1 Chronic hyperglycemia leads to increased oxidative stress, inflammation, and hypoxia, all inducing alterations of the neurovascular unit of the retina. 2 The neurovascular unit of the retina consists of retinal neurons and glial cells (microglia and macroglia), endothelial cells, and pericytes. 2 All these cell types undergo specific modifications induced by DM, even before the onset of clinical signs of DR, as reported by the experimental studies in animals and humans with DM. [3] [4] [5] [6] [7] [8] Retinal neurodegeneration, histologically consisting in neural apoptosis and glial cell activation leading to ganglion cell death, ultimately may determine the thinning of the inner retinal layers, is believed to occur before clinically visible retinal microvascular damage. 4, 5, [9] [10] [11] [12] [13] [14] With recent advent of noninvasive retinal imaging techniques such as spectral domain optical coherence tomography (SD-OCT) and SD-OCT angiography, changes in thickness of single retinal layers as well as modifications of macular capillary network have been evaluated in patients with DM with or without DR. A decrease in retinal nerve fiber layer (NFL) and ganglion cell layer (GCL) thickness has been reported in patients with DM, even without clinical signs of DR. 13, [15] [16] [17] [18] Alterations of the macular capillary network (especially foveal avascular zone [FAZ] enlargement and capillary loss in the perifoveal area in deep capillary plexus [DCP] and/or superficial capillary plexus [SCP] ) have been reported in patients with DM without clinical signs of DR, when compared with subjects with no DM. [19] [20] [21] There are very limited data on the direct evaluation and comparisons between microvascular changes detected on OCT angiography and retinal layer thickness changes in patients with DM and no clinical signs of DR. 20 , 21 Dimitrova et al 20 evaluated changes in DCP and choroid in patients with DM Type 2 and without clinical signs of DR. Simonett et al 21 evaluated a population of patients with DM Type 1 and without clinical signs of DR. In this study, we aimed to assess and compare changes in inner retinal layer thickness and early microvascular changes detected on OCT angiography in patients with DM Type 1 and DM Type 2 and without clinical signs of DR.
Material and Methods

Patients
This is a prospective, cross-sectional, comparative and consecutive case-control series of 90 subjects (90 eyes), consisting of normal subjects (no DM) and patients with DM without clinical signs of DR. The right eye was included in the study. Just in case of poor quality OCT angiography images (including the presence of artifacts) in the right eye, the left eye was included. All patients with DM were recruited from the Medical Retina service at the University Hospital Maggiore della Carita' in Novara. All subjects underwent blood pressure measurement, anamnestic collection of data including type of DM, value of hemoglobin A1c (HbA1c) complete ophthalmologic examination with best-corrected visual acuity determination, intraocular pressure (IOP) measurement, slit-lamp fundus examination with 90D lens, color fundus photograph of the macula, SD-OCT, and OCT angiography performed on the same day. Inclusion criteria were patients older than 18 years with DM (Type 1 and Type 2, diagnosis confirmed by the diabetologist) without clinical signs of DR determined on slit-lamp fundus examination and confirmed on color fundus photograph of the macula; healthy subjects (with normal glucose test, control group); no history of ocular hypertension (IOP . 21 mmHg), glaucoma, uveitis, or neurodegenerative disease (e.g., Alzheimer disease, Parkinson, etc); and patients/subjects who accepted to participate. Major exclusion criteria were previous intraocular treatment (laser, intravitreal injections, and vitreoretinal surgery); cataract surgery within 6 months; any anti-inflammatory/steroids topical therapy; refractive error .+4D; any stage of DR or diabetic macular edema; and significant media opacity that precluded good quality fundus imaging and examination. The study was conducted in accordance with the tenets of the Declaration of Helsinki and with approval of the institutional Ethics Committee. All patients accepted to participate and signed the consent form.
Visual Acuity
Best-corrected distance visual acuity for each eye was measured by a certified tester using standard Early Treatment Diabetic Retinopathy Study (ETDRS) protocol at 4-m distance with a modified ETDRS distance chart illuminator (Precise vision, Bloomington, IL). Visual acuity was scored as the total number of letters read correctly (ETDRS score) and (also expressed in logarithm of the minimum angle of resolution).
Imaging
Spectral domain optical coherence tomography and optical coherence tomography angiography. Spectral domain OCT and OCT angiography were performed using the swept-source OCT, DRI OCT Triton plus (Topcon Medical Systems Europe, Milano, Italy). This instrument uses a 1,050-nm wavelength, with a scanning speed of 100,000 AScans/second. Following scan patterns were performed: a linear B-scan (12 mm length) centered on the fovea at 0°; 3D macula map covering central area of 7 mm · 7 mm; and OCT angiography maps covering central 3 mm · 3 mm area and 6 mm · 6 mm area.
Spectral domain optical coherence tomography segmentation and measurement. Following retinal layers were evaluated from the automatic segmentation of 3D map obtained with DRI OCT Triton plus OCT instrument (software version 10.07.003.03): retinal NFL from inner limiting membrane (ILM) to NFL; GCL+ complex-from NFL/GCL interface to inner plexiform layer (IPL)/inner nuclear layer (INL); GCL++ complex-from ILM/NFL interface to IPL/INL; and (full) retinal thickness-from ILM to interdigitation zone. 22 Automatic evaluation of the specific retinal layer thickness and full-retinal thickness was performed in 9 ETDRS areas and evaluated as (central subfield [CSF] retinal thickness-circular area with 1 mm diameter centered on the fovea); inner rings (mean value of 4 inner quadrants with diameter of 3 mm); and outer rings (mean value of 4 outer quadrants with 6 mm diameter).
Optical coherence tomography angiography scans evaluation. Optical coherence tomography angiography (OCTA) scans obtained within 3 mm · 3 mm were used for both quantitative and qualitative evaluations. All evaluations were separately performed at the level of SCP and DCP. The built-in software segmentation algorithm was used to define SCP and DCP on en face OCT angiograms. The SCP slab was obtained from the ILM to 15.6 mm above the IPL/INL interface. The DCP slab was obtained from the IPL/INL interface (above 15.6 mm) to the IPL/INL interface (below 70.2 mm). Only good quality OCTA images were considered for analyses, excluding those that had presence of artifacts such as double vessel pattern, dark areas from blinks, or motion artifacts, and those with signal strength index below 50.
Quantitative parameters included: 1) area of the FAZ delimitated using the tool caliper area available within software IMAGENET 6 (version 1.17.9720; Topcon Medical Systems, Inc, Oakland, NJ). After manual delimitation of the FAZ, the software automatically calculates the area in square millimeters (mm 2 ); and 2) number of focally dilated endings of the capillaries (visible only on OCTA and counted within 3 mm area). 23, 24 Qualitative parameters included 1) presence of regular (defined as having oval or round shaped with regular and clear contour) 24 or irregular (defined as asymmetrical) FAZ; 2) presence of area of capillary loss/reduced capillary density; and 3) presence of tortuosity and/or beadings of the capillaries (Figure 1 ). To minimize the errors when evaluating the area of the FAZ in the DCP (because of the projection artifacts), sequential en face images at different depths were carefully examined. 25 All measurements and evaluations were performed by 2 trained graders (A.M. and M.A.), independently, masked to the clinical data of patients, on 3-mm scan area, zooming the image to have greater magnification and evaluate more easily details, and (if necessary) using also the reverse mode (in which vessels are black and the background is white, for better definition of details) ( Figure 2 ). In case of disagreement, the experienced medical retina specialist (S.V.) made a final adjudication.
Statistical Methods
The summary of parameters has been made by means of usual methods used for descriptive statistics: mean value, SD, and range for continuous numeric variables; frequency distribution, absolute, and relative (percentage), for qualitative variables.
Sample characteristics (age, systolic pressure, diastolic pressure, HbA1c, best-corrected visual acuity, and IOP) have been compared between patients with DM and controls by means of Student's t-test. Comparisons among groups (DM Type 1 and DM Type 2, and controls) have been made by means of one-way analysis of variance (ANOVA) followed by post hoc Bonferroni test for multiple comparisons. Preliminary analysis of potential confounders (age, sex, blood pressure, and spherical equivalent) on OCT and OCTA parameters was performed. Only adjustment for age and blood pressure was applied in the analyses.
Optical Coherence Tomography Parameters
Mean values of retinal thickness (full-retinal thickness, NFL thickness, GCL+ thickness, and GCL++ thickness) have been compared between patients with DM and controls, and among DM Type 1, DM Type 2, and controls by means of 3 factor with interaction ANOVA for repeated-measures analysis, adjusted for age. Comparison between DM Type 1 and DM Type 2 has been adjusted also for the duration of DM. Retinal thickness determined in the nine ETDRS quadrants was summarized into three values referred as central subfield (CSF quadrant), inner ring (average value of inner superior, inner nasal, inner inferior, and inner temporal quadrant values), and outer ring (average value of outer superior, outer nasal, outer inferior, and outer temporal quadrant values). Factors of the model were Group (patients with DM and controls in one analysis, DM Type 1, DM Type 2, and controls in the other), Sector (CSF, inner ring, and outer ring), and the interaction Group by Sector. However, particular interest has been placed to significance of Group factor (which tested differences among overall mean retinal thicknesses) and to interaction factor (which tested differences among retinal thickness profiles). Comparisons have been adjusted for patient's age and in case of significant result, post hoc tests for multiple comparisons with Bonferroni correction were applied.
Optical Coherence Tomography Angiography Parameters
Mean values of FAZ area extension and number of focally dilated capillaries in the SCP and DCP have been compared among groups (patients with DM vs. controls, and DM Type 1 vs. DM Type 2 vs. controls) by means of one-way ANOVA analysis adjusted for patient's age and blood pressure and followed by Bonferroni post hoc test for multiple comparisons. Comparison between DM Type 1 and DM Type 2 has been adjusted also for the duration of DM. Association between Group and presence of regular/irregular FAZ, presence of area of capillary loss/reduced capillary density, and presence of tortuosity/beadings have been assessed by means of logistic regression model adjusted for patient's age and blood pressure. Association was expressed in terms of odds ratios and relative 95% Wald confidence interval.
Correlations Among Optical Coherence Tomography and Optical Coherence Tomography Angiography Parameters
Multiple linear regression models with stepwise selection of independent variables have been used to assess the relationship between retinal thickness (dependent variable)-one model for each parameters: full-retinal thickness, NFL layer, GCL+, and GCL++-and OCT angiography parameters. Patient's age and blood pressure (systolic and diastolic) were taken into account. In case of patients with DM Type 1 and Type 2, the duration of DM was also taken into account. Two models have been estimated, one for each of the following sectors: CSF, inner ring. Qualitative variables have been coded as follows before entering the model: FAZ regularity, 0 = regular, 1 = irregular; capillary loss, 0 = absent, 1 = present; and tortuosity/beadings, 0 = absent, 1 = present.
All the analyses have been performed by means of SAS version 9.3 (SAS, Cary, NC) statistical software. All statistical tests have been considered significant when P , 0.05.
Results
Of 90 examined subjects (90 eyes, 86 right eyes, 4 left eyes), 60 were patients with DM with no clinical signs of DR and 30 were healthy subjects (with no DM). Of 60 patients with DM, 24 patients had DM Type 1 and 36 patients had DM Type 2. Systemic and ocular findings (mean age, HbA1c, duration of DM, blood pressure, best-corrected visual acuity, and IOP values) are reported in Table 1 . Table 2 shows mean values of retinal thickness (automatically measured by the instrument) of the full retina, NFL, GCL+ complex, and GCL++ complex divided by rings (CSF, inner ring, and outer ring) and groups (normal subjects, all patients with DM and separately DM Type 1 and DM Type 2). After adjusting for age, there was a different thickness profile in GCL++ complex among 3 examined groups (control, patients with DM Type 1, and DM Type 2), P = 0.049, (ANOVA) in the 3 different rings. Such a model estimated that GCL++ complex in the inner ring was thinner in patients with DM Type 1 (114.9 mm ± 8.3) versus controls, although not reaching statistical significance (118.0 mm ± 8.2, Bonferroni post hoc test for multiple comparison, P = 0.0981).
After adjusting for age and DM duration, GCL+ complex (49.4 mm ± 7.3 vs. 43.6 mm ± 9.6, P = 0.0099) and GCL++ complex (57.2 mm ± 10.8 vs. 50.5 ± 10.2 mm, P = 0.0367) were significantly thicker in patients with DM Type 1 vs. DM Type 2 in the CSF (Table 2) . Table 3 shows data of parameters evaluated on OC-TA, adjusted for patient's age, blood pressure, and DM duration (in case of patients with DM). All evaluated parameters both quantitative and qualitative were significantly different in patients with DM versus controls in both SCP and DCP (Table 3 ). In particular, the area of FAZ was significantly larger in patients with DM Type 1 versus controls in both SCP (P = 0.05) and DCP (P , 0.001) and in patients with DM Type 1 versus DM Type 2 only in DCP (P , 0.0001); the number of focally dilated endings of the capillaries was higher in patients with DM Type 1 versus controls in both SCP (P , 0.001) and DCP (P , 0.0001); and in patients with DM Type 2 versus controls only in DCP (P = 0.007) ( Table 3) . Logistic regression analysis (adjusted for patient's age and blood pressure) showed greater association between all evaluated qualitative parameters in patients with DM Type 1 and almost all (exception for capillary irregularities in the SCP) for patients with DM Type 2 versus control group (Table 3) . Table 4 shows statistically significant correlations between OCT and OCTA parameters. Statistically significant correlations with retinal thickness include almost all parameters evaluated on OCT angiography in the SCP in patients with DM Type 1, whereas only the presence of areas of capillary loss and FAZ area in the SCP in patients with DM Type 2. In particular, the area of FAZ in SCP inversely correlated with NFL thickness in the CSF in patients with DM Type 2, whereas the area of FAZ in DCP inversely correlated with NFL thickness in the CSF in patients with DM Type 1.
The highest correlations were found between perifoveal capillary loss in the SCP and GCL+ and GCL++ thickness in the inner ring in patients with DM Type 1 and perifoveal capillary loss in the SCP and NFL thickness in the CSF and the inner ring in patients with DM Type 2.
Discussion
In this study, we report on early microvascular and retinal thickness changes in patients with DM and without clinical signs of DR, evaluating further and separately patients with DM Type 1 and DM Type 2. All quantitative and qualitative parameters evaluated on OCTA in the SCP and DCP were significantly different in patients with DM when compared with healthy controls. In particular, FAZ area was larger and irregular, the number of focally dilated endings of the capillaries (detected only on OCTA) was higher, areas of perifoveal capillary loss, and tortuosity and beadings were more numerous in both SCP and DCP in patients with DM when compared with healthy subjects.
When evaluating separately patients with DM Type 1 and DM Type 2, all quantitative and qualitative parameters evaluated on OCT angiography resulted altered in both SCP and DCP in patients with DM Analysis of variance adjusted for patient's age and blood pressure, test versus control group: a P = 0.0582; b P = 0.0003; c P = 0.0005; and d P , 0.0001.
Post hoc Bonferroni test versus control group after ANOVA adjusted for patient's age and blood pressure: e P = 0.0189; f P , 0.0001; g versus Type II group, adjusted also for DM duration, P = 0.030; h P = 0.0013; i P , 0.0.001; j P = 0.0118.
Logistic regression analysis adjusted for patient's age and blood pressure, odds ratios (95% confidence interval) versus control group: Type 1 vs. controls. In DM Type 2, almost all qualitative parameters (except the presence of tortuosity/beadings in the SCP) were found different, whereas the higher number of focally dilated endings of the capillaries in the DCP was the only quantitative parameter found different versus controls. The meaning of these capillary alterations is not yet fully known. Whether they may represent microaneurysms, which are not visible on careful fundus examination, or they are blind-end dilated interrupted terminal vessels that may be surrounded by an area of capillary loss remains to be further evaluated and confirmed by studies using also fluorescein angiography. 23, 24, 26, 27 In addition, patients with DM Type 1 had larger FAZ area versus patients with DM Type 2 in the DCP. Although data from this study cannot be directly correlated with the data available in the literature on OCT angiography parameters in patients with DM and without clinical signs of DR, because of different characteristics of examined patients (considering together patients with DM Type 1 and Type 2, or only separately patients with DM Type 1 but also with clinical signs of DR), some similarities or differences could be drawn. De Carlo et al 19 reported on increased prevalence in changes to the FAZ (increased FAZ area and presence of FAZ remodeling) and capillary nonperfusion in patients with DM (considering together Type 1 and Type 2) and no clinical signs of DR. The same authors reported that vascular tortuosity was present in similar percentage in both controls and patients with DM, and could be a variant of normal, and thus cannot be used as the OCTA screening parameter for retinal vascular change in DM. 19 However, the authors did not report on blood pressure data and differences between the groups. On the contrary, in this study, after adjusting for blood pressure differences both venous beading and vascular tortuosity were found more frequent in patients with DM Type 1 and DM Type 2 versus nondiabetic subjects. Thus, the significance of microvascular abnormalities in patients with DM and no clinical signs of DR may warrant further evaluation. Simonett et al 21 evaluated patients with DM Type 1 and without DR or with mild nonproliferative DR and reported decreased parafoveal vessel density (that could be compared with parafoveal capillary nonperfusion) only in the DCP, and no changes in the FAZ area were found in neither SCP nor DCP. Dimitrova et al 20 documented decreased parafoveal vessel density in the SCP In brackets, statistically significant (P , 0.05) regression coefficients from the multiple regression model of each OCT parameter versus Angio-OCT parameters (stepwise selection criterion) adjusted for patient's age and blood pressure (systolic and diastolic) and in DM groups adjusted also for DM duration. and DCP and FAZ area increase in the SCP in patients with DM (mostly Type 2) and no DR when compared with control subjects. Choi et al, 28 using an ultrahigh speed swept-source OCT angiography prototype, documented retinal microvascular abnormalities (such as capillary dropout, dilated capillary loops, tortuous capillary branches, patches of reduced capillary perfusion, irregular FAZ contours, and/or FAZ enlargement) in both SCP, intermediate and DCP, in 18 of the 51 eyes with DM and no clinical signs of DR (with no specification of DM type). Moreover, these authors reported focal or diffuse choriocapillaries flow impairment in almost half of the evaluated patients without DR.
Data from this study may indicate that both SCP and DCP are precociously altered in patients with DM Type 1 and without clinical signs of DR, whereas in patients with DM Type 2, DCP is more precociously involved. To the best of our knowledge, no data are currently available on direct comparison between patients with DM Type 1 and Type 2 at the preclinical stage of DR.
Thinning of the inner retinal layers in the macula in DM with or without DR has been reported in the literature. Scarinci et al 18 recently reported a significant thinning of the GCL layer in patients with DM Type 1 and no DR. Van Dijk et al 16 documented a decrease in NFL, GCL, and IPL thickness, only in patients with minimal DR compared with controls. Vujosevic and Midena 13 documented decreased NFL thickness in patients with no DR and with nonproliferative DR, mostly with DM Type 2. Pierro et al 29 reported reduced GCL complex thickness and choroidal thickness in patients with DM Type 2 and no DR. In this study, thinner absolute inner parafoveal retinal thickness values in DM Type 1 (but without reaching statistical significance) were documented when compared with normal subjects. A systematic review of ocular neurodegenerative changes assessed by OCT in the macula and the optic nerve head and by corneal confocal microscopy (evaluating nerve fibers in the cornea) in patients with DM and no DR or with mild nonproliferative DR reported that ocular neurodegenerative changes can occur even at an early stage, when DR or polyneuropathy, as assessed with conventional methods, are not present. 30 More precisely, no retinal layer thickness changes in DM Type 1 and a significantly thinner NFL thickness in DM Type 2 versus individuals without diabetes were reported. 15, [30] [31] [32] [33] [34] [35] [36] [37] In case of presence of DR, there was further reduction in inner retinal thickness when compared with no DR. 30 These findings suggested that the thinning of the retinal layers is an early sign of neurodegeneration in DR (as well as changes in corneal nerve fibers is an early sign of diabetic polyneuropathy) that becomes more evident when DR or polyneuropathy is present. 30 In this study, after adjusting for age and DM duration, GCL+ and GCL++ complex thicknesses were significantly higher in patients with DM Type 1 versus DM Type 2 in the CSF. The exact mechanism leading to this finding is not known. One hypothesis may implicate a protective role of more intensive insulin treatment on retinal ganglion cells already reported in experimental studies, thus the thicker inner retina in DM Type 1. 38, 39 Another hypothesis may see reported differences in complication characteristics in patients with DM Type 2 versus DM Type 1, that included more prevalent peripheral neuropathy and cardiovascular disease in DM Type 2, independent of disease duration. 40 Kim et al 41 documented a decrease in GCL-IPL thickness that was positively correlated with the presence of peripheral nerve conduction and cardiac autonomic neuropathy in DM Type 2 and no DR or with mild nonproliferative DR. These findings may explain the thinner inner retina in DM Type 2 when corrected for age difference and DM duration in this study.
Major limitation of this study may include the crosssectional design, especially for the evaluation of the shape and the area of the FAZ, which may vary consistently even in normal individuals. Therefore, only a prospective and longitudinal analysis could confirm the exact correlation between the FAZ parameters and the inner retinal thickness. Another limitation may include the presence of projection artifacts (decorrelation tail) in the evaluation of the DCP, intrinsic to the OCTA technique. We tried to overcome it (as far as possible) with careful examination of sequential en face images at different depths. 25 In conclusion, this study documents and correlates very early and specific microvascular and neuronal changes in patients with DM Type 1 and DM Type 2 and without clinical signs of DR. Optical coherence tomography angiography allows for detection of microvascular changes even before clinical signs of DR are present, which can be related to inner retinal thinning (retinal neurodegeneration). Furthermore, larger and longitudinal studies are needed to better evaluate and correlate microvascular and neural changes in the retina in DM.
